百奥泰:与Stein就BAT2306(司库奇尤单抗)注射液签署授权许可及生产、供货和商业化协议

GoldenOctober2024
BAT2,02%

金十数据12月16日讯,公司与SteinCares签署授权许可及生产、供货和商业化协议,将公司的BAT2306(司库奇尤单抗)注射液在巴西以及其余拉丁美洲地区市场的独占的产品商业化权益有偿许可给Stein。交易金额为首付款及里程碑款总金额最高至800万美元,其中包括120万美元首付款、累计不超过680万美元里程碑付款,以及净销售额的两位数百分比作为收入分成。

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Commento
0/400
Nessun commento
Trading di criptovalute ovunque e in qualsiasi momento
qrCode
Scansiona per scaricare Gate app
Notizie
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)